Dr. Claire Ann Mulvihill, MD

Dr. Mulvihill practices at The Dermatology Center of New Jersey in Bridgewater, New Jersey.

Dr. Mulvihill's NPI, 1417057498, was assigned on September 22, 2006. Dr. Mulvihill graduated from State University of New York at Buffalo School of Medicine in 1988. Dr. Mulvihill holds New Jersey license 25MA06956500.

Dr. Mulvihill's primary practice is The Dermatology Center of New Jersey, at 1376 Plymouth Rd, Bridgewater, NJ 08807 in Somerset County. The practice phone is (908) 393-9755.

Dr. Mulvihill's primary practice is The Dermatology Center of New Jersey in Bridgewater, New Jersey. The medical group on file is The Dermatology Center of New Jersey. Dmand AI also links Dr. Mulvihill to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mulvihill practices. Vendor and product names are available with a free account.

Dermatology is Dr. Mulvihill's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Mulvihill is licensed in New Jersey.

CMS data shows 553 Medicare services from Dr. Mulvihill across 8 procedure codes in 2024, for 204 Medicare patients. Medicare paid $28,972 for them. Every service was in an office.

CMS counts 204 Medicare patients who saw Dr. Mulvihill in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mulvihill's median patient age at 58, with 56% women.

In 2024, Dr. Mulvihill wrote 250 Medicare Part D claims for 122 patients. 85% of them were for generic drugs. CMS names the drug for 119 of them, across 7 drugs with 11 or more claims each, at $5,913 in total drug cost. In 2023, CMS named 173 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Mulvihill for performance year 2024, reported as part of a group. Dr. Mulvihill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 118 procedures of removal of skin lesions by Dr. Mulvihill, more than 76% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 504 general payments to Dr. Mulvihill from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,255.

Dr. Mulvihill graduated from State University of New York at Buffalo School of Medicine in 1988.